Résultats de la recherche - 5 results
WHO Guidelines on Post approval Changes- Appendix 2+3 Reporting procedures and data requirements for quality changes to antigens + finished products
Publication Type: Scientific poster, presentation or proceeding Authors: Tesolin, L. Source: Workshop on management of post approval changes, 03-05/12/2024, Hanoi-Viet Nam, WHO, Hanoi, Viet Nam (2024) Keywords: post approval changes vaccine Health Topics: ...
FT-IR spectroscopy as a rapid method for Salmonella spp. typing
LDA. This can be explained by the selected spectral region, which reflects the carbohydrate composition, the main components of the somatic O-antigens determining the serogroup. Discriminating serotypes ...
Development of a multiplex immunoassay for simultaneous detection of antigens in DTaP vaccines
antigens present in the formulation) to monitor the consistency of antigen quantity and quality throughout the production process of DT aP vaccines from two manufacturers (coded HuA and HuB). A first work ...
Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.
components that potentiate the immune responses to an antigen and/or modulate it towards the desired immune responses. Adjuvants can be classified according to their source, mechanism of action, or physical or ...
Implementation over the past 20 years of the 3R's principle for batch release at the Scientific Institute of Public Health, Belgium (IPH).
DTP a-Hepb and DTP a- IPV vaccines to the first final bulk that is formulated with a new bulk antigen instead of each final bulk. This reduction fitted in the framework of the possibility within the ...